非甾体抗炎药预防结直肠癌：敏感性问题。 - Suppr

Suppr

超能文献

NSAIDs to prevent colorectal cancer: a question of sensitivity.

作者信息

Elder D J, Paraskeva C

出版信息

Gastroenterology. 1997 Dec;113(6):1999-2003.

PMID:9394741

Abstract

摘要

相似文献

NSAIDs to prevent colorectal cancer: a question of sensitivity.

Gastroenterology. 1997 Dec;113(6):1999-2003.

Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.

Nat Rev Cancer. 2001 Oct;1(1):11-21. doi: 10.1038/35094017.

[Specificity, action, indications and safety. Criteria for the use of COX-2 inhibitors].

Pharm Unserer Zeit. 2002;31(2):190-8. doi: 10.1002/1615-1003(200203)31:2<190::AID-PAUZ190>3.0.CO;2-S.

[New anti-inflammatory analgetics--are they needed?].

Duodecim. 1999;115(20):2217-24.

Aspirin and the prevention of colorectal cancer.

N Engl J Med. 2003 Jun 12;348(24):2466-7; author reply 2466-7.

[Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma].

Ned Tijdschr Geneeskd. 2003 Nov 8;147(45):2207-12.

[The use of non-steroidal anti inflammatory drugs (NSAIDs)--COX-2 inhibitors].

Harefuah. 2002 Oct;141(10):920-1.

[Cyclooxygenase 2 inhibitors and adenomatous polyposis coli].

Bull Cancer. 2004 May;91 Spec No:S85-8.

COX-2 inhibition as a tool to treat and prevent colorectal cancer.

Crit Rev Oncol Hematol. 2004 Nov;52(2):81-101. doi: 10.1016/j.critrevonc.2004.08.004.

[Colorectal cancer and inhibition of cyclooxygenase-2].

Dtsch Med Wochenschr. 2002 Jun 7;127(23):1256-8. doi: 10.1055/s-2002-32104.

引用本文的文献

Pharmacological evaluation and preliminary pharmacokinetics studies of a new diclofenac prodrug without gastric ulceration effect.

Int J Mol Sci. 2012 Nov 19;13(11):15305-20. doi: 10.3390/ijms131115305.

Purified intestinal alkaline sphingomyelinase inhibits proliferation without inducing apoptosis in HT-29 colon carcinoma cells.

J Cancer Res Clin Oncol. 2003 Oct;129(10):577-82. doi: 10.1007/s00432-003-0466-2. Epub 2003 Aug 12.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

NSAIDs to prevent colorectal cancer: a question of sensitivity.

作者信息

Elder D J, Paraskeva C

出版信息

Gastroenterology. 1997 Dec;113(6):1999-2003.

PMID:9394741

Abstract

摘要

相似文献

NSAIDs to prevent colorectal cancer: a question of sensitivity.

Gastroenterology. 1997 Dec;113(6):1999-2003.

Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.

Nat Rev Cancer. 2001 Oct;1(1):11-21. doi: 10.1038/35094017.

[Specificity, action, indications and safety. Criteria for the use of COX-2 inhibitors].

Pharm Unserer Zeit. 2002;31(2):190-8. doi: 10.1002/1615-1003(200203)31:2<190::AID-PAUZ190>3.0.CO;2-S.

[New anti-inflammatory analgetics--are they needed?].

Duodecim. 1999;115(20):2217-24.

Aspirin and the prevention of colorectal cancer.

N Engl J Med. 2003 Jun 12;348(24):2466-7; author reply 2466-7.

[Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma].

Ned Tijdschr Geneeskd. 2003 Nov 8;147(45):2207-12.

[The use of non-steroidal anti inflammatory drugs (NSAIDs)--COX-2 inhibitors].

Harefuah. 2002 Oct;141(10):920-1.

[Cyclooxygenase 2 inhibitors and adenomatous polyposis coli].

Bull Cancer. 2004 May;91 Spec No:S85-8.

COX-2 inhibition as a tool to treat and prevent colorectal cancer.

Crit Rev Oncol Hematol. 2004 Nov;52(2):81-101. doi: 10.1016/j.critrevonc.2004.08.004.

[Colorectal cancer and inhibition of cyclooxygenase-2].

Dtsch Med Wochenschr. 2002 Jun 7;127(23):1256-8. doi: 10.1055/s-2002-32104.

引用本文的文献

Pharmacological evaluation and preliminary pharmacokinetics studies of a new diclofenac prodrug without gastric ulceration effect.

Int J Mol Sci. 2012 Nov 19;13(11):15305-20. doi: 10.3390/ijms131115305.

Purified intestinal alkaline sphingomyelinase inhibits proliferation without inducing apoptosis in HT-29 colon carcinoma cells.

J Cancer Res Clin Oncol. 2003 Oct;129(10):577-82. doi: 10.1007/s00432-003-0466-2. Epub 2003 Aug 12.